Literature DB >> 31421278

Secondary loss of response to mepolizumab in severe eosinophilic asthma.

Maxime Cormier1, Simone Chaboillez1, Catherine Lemiere2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31421278     DOI： 10.1016/j.jaip.2019.08.005

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  1 in total

1.  Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients.

Authors:  Maruša Kopač Šokić; Matija Rijavec; Peter Korošec; Urška Bidovec-Stojkovič; Izidor Kern; Romana Vantur; Sabina Škrgat
Journal:  J Pers Med       Date:  2022-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.